SCHEMBL2880810

SCHEMBL2880810

COc1ccc(-c2cccc3[nH]ncc23)c(Oc2cnn(C)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 3/20 0.47
BRD4 O60885 1/20 0.46
PIK3CA P42336 3/20 0.44
PIK3CD O00329 1/20 0.44
PIK3CB P42338 1/20 0.44
PIK3CG P48736 1/20 0.44
PRKDC P78527 1/20 0.44
BRAF P15056 2/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
MAPT P10636 4/20 0.42
ALOX15 P16050 4/20 0.42
MAPK1 P28482 3/20 0.42
ALOX12 P18054 3/20 0.42
LMNA P02545 3/20 0.42
USP2 O75604 2/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2879628 0.88 BRD4 (0.50) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3433766 0.83 METAP2 (0.51) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3435032 0.82 PIK3CA (0.42) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL28924973 0.78 PIK3CA (0.56) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL15876525 0.77 METAP2 (0.44) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3435046 0.76 BRD4 (0.56) METAP2BRD4PIK3CABRAFCCNA2
SCHEMBL28635804 0.75 BRAF (0.51) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3435497 0.75 METAP2 (0.46) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL3432778 0.73 METAP2 (0.45) METAP2BRD4PIK3CAPIK3CDPIK3CB
SCHEMBL28961950 0.70 BRAF (0.61) METAP2BRD4PIK3CABRAFMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010059788-A1 PYRAZOLOPYRIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2010-05-27 WO claimed
CN-106659765-B Use of dianhydrogalactitol and analogs or derivatives thereof for treating non-small cell lung cancer and ovarian cancer 德玛医药 2021-08-13 CN disclosed